Form 4: ProKidney Corp. Executive Darin J. Weber Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Darin J. Weber, Chief Regulatory Officer of ProKidney Corp., sold 17,238 Class A Ordinary Shares at an average price of $2.8203 on June 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On June 18, 2024, Darin J. Weber, the Chief Regulatory Officer of ProKidney Corp., sold 17,238 Class A Ordinary Shares.
- The sale was executed at a weighted average price of $2.8203 per share.
- The transactions occurred under a Rule 10b5-1 trading plan adopted on November 20, 2023.
- Following the reported transaction, Weber directly owns 120,718 Class A Ordinary Shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a routine transaction under a pre-existing trading plan. There is no indication of positive or negative implications for the company.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity. It is common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of trading on inside information.
Key Dates
| Date | Description |
|---|---|
| November 20, 2023 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| June 18, 2024 | Date of the transaction (sale of shares) |
| June 20, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.